Corvus Pharmaceuticals, Inc. SEC filings CRVS
Corvus Pharmaceuticals, Inc. has 583 filings in SEC EDGAR's recent list, going back to Dec 8, 2014. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 15, 2024 | — |
| CORRESP | Letter to the SEC | Aug 13, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2024 | — |
| EFFECT | Filing | May 8, 2023 | — |
| CORRESP | Letter to the SEC | May 4, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2023 | — |
| SEC STAFF LETTER | Filing | Mar 29, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 1, 2021 | — |
| EFFECT | Filing | Mar 19, 2020 | — |
| CORRESP | Letter to the SEC | Mar 17, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 24, 2018 | — |
| CORRESP | Letter to the SEC | Aug 17, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2018 | — |
| CT ORDER | Filing | Sep 11, 2017 | — |
| EFFECT | Filing | Jun 9, 2017 | — |
| CORRESP | Letter to the SEC | Jun 7, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2017 | — |
| CT ORDER | Filing | Mar 25, 2016 | — |
| EFFECT | Filing | Mar 22, 2016 | — |
| CERTNAS | Auto-generated paper document | Mar 21, 2016 | — |
| CORRESP | Letter to the SEC | Mar 18, 2016 | — |
| CORRESP | Letter to the SEC | Mar 18, 2016 | — |
| 8-A12B | Filing | Mar 16, 2016 | — |
| CORRESP | Letter to the SEC | Feb 8, 2016 | — |
| CORRESP | Letter to the SEC | Jan 4, 2016 | — |
| DRSLTR | Filing | Dec 10, 2015 | — |
| DRS/A | Filing | Dec 10, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2015 | — |
| DRS | Filing | Nov 6, 2015 | — |
| D | Filing | Sep 25, 2015 | — |
| D | Filing | Dec 8, 2014 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CRVS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1626971
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.